Literature DB >> 25873485

NHANES 2009-2012 Findings: Association of Sexual Behaviors with Higher Prevalence of Oral Oncogenic Human Papillomavirus Infections in U.S. Men.

Anil K Chaturvedi1, Barry I Graubard1, Tatevik Broutian2, Robert K L Pickard2, Zhen-Yue Tong2, Weihong Xiao2, Lisa Kahle3, Maura L Gillison4.   

Abstract

The incidence of human papillomavirus (HPV)-positive oropharyngeal cancers is higher and increasing more rapidly among men than women in the United States for unknown reasons. We compared the epidemiology of oral oncogenic HPV infection between men and women ages 14 to 69 years (N = 9,480) within the U.S. National Health and Nutritional Examination Surveys (NHANES) 2009-2012. HPV presence was detected in oral DNA by PCR. Analyses were stratified by gender and used NHANES sample weights. Oral oncogenic HPV prevalence was higher among men than women (6.6% vs. 1.5%, P < 0.001), corresponding to 7.07 million men versus 1.54 million women with prevalent infection at any point in time during 2009-2012. Prevalence increased significantly with age, current smoking, and lifetime number of sexual partners for both genders (adjusted Ptrend < 0.02). However, men had more partners than women (mean = 18 vs. 7, P < 0.001). Although oncogenic HPV prevalence was similar for men and women with 0 to 1 lifetime partners, the male-female difference in prevalence significantly increased with number of lifetime partners (adjusted prevalence differences for none, 1, 2-5, 6-10, 11-20, and 20+ partners = 1.0%, 0.5%, 3.0%, 5.7%, 4.6%, and 9.3%, respectively). Importantly, the per-sexual partner increase in prevalence was significantly stronger among men than among women (adjusted synergy index = 3.3; 95% confidence interval, 1.1-9.7), and this increase plateaued at 25 lifetime partners among men versus 10 partners among women. Our data suggest that the higher burden of oral oncogenic HPV infections and HPV-positive oropharyngeal cancers among men than women arises in part from higher number of lifetime sexual partners and stronger associations with sexual behaviors among men. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2015        PMID: 25873485      PMCID: PMC4470779          DOI: 10.1158/0008-5472.CAN-14-2843

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  35 in total

1.  Flexible regression models with cubic splines.

Authors:  S Durrleman; R Simon
Journal:  Stat Med       Date:  1989-05       Impact factor: 2.373

2.  Confidence intervals for measures of interaction.

Authors:  S F Assmann; D W Hosmer; S Lemeshow; K A Mundt
Journal:  Epidemiology       Date:  1996-05       Impact factor: 4.822

Review 3.  EUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection.

Authors:  Anna R Giuliano; Alan G Nyitray; Aimée R Kreimer; Christine M Pierce Campbell; Marc T Goodman; Staci L Sudenga; Joseph Monsonego; Silvia Franceschi
Journal:  Int J Cancer       Date:  2014-07-26       Impact factor: 7.396

4.  Application of computer-assisted interviews to sexual behavior research.

Authors:  P Kissinger; J Rice; T Farley; S Trim; K Jewitt; V Margavio; D H Martin
Journal:  Am J Epidemiol       Date:  1999-05-15       Impact factor: 4.897

Review 5.  The effects of hormones on sex differences in infection: from genes to behavior.

Authors:  S L Klein
Journal:  Neurosci Biobehav Rev       Date:  2000-08       Impact factor: 8.989

6.  Epidemiologic classification of human papillomavirus types associated with cervical cancer.

Authors:  Nubia Muñoz; F Xavier Bosch; Silvia de Sanjosé; Rolando Herrero; Xavier Castellsagué; Keerti V Shah; Peter J F Snijders; Chris J L M Meijer
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

7.  Natural history of anal vs oral HPV infection in HIV-infected men and women.

Authors:  Daniel C Beachler; Gypsyamber D'Souza; Elizabeth A Sugar; Wiehong Xiao; Maura L Gillison
Journal:  J Infect Dis       Date:  2013-04-17       Impact factor: 5.226

8.  Lack of association of alcohol and tobacco with HPV16-associated head and neck cancer.

Authors:  Katie M Applebaum; C Sloane Furniss; Ariana Zeka; Marshall R Posner; Judith F Smith; Janine Bryan; Ellen A Eisen; Edward S Peters; Michael D McClean; Karl T Kelsey
Journal:  J Natl Cancer Inst       Date:  2007-11-27       Impact factor: 13.506

9.  Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers.

Authors:  Anil K Chaturvedi; William F Anderson; Joannie Lortet-Tieulent; Maria Paula Curado; Jacques Ferlay; Silvia Franceschi; Philip S Rosenberg; Freddie Bray; Maura L Gillison
Journal:  J Clin Oncol       Date:  2013-11-18       Impact factor: 44.544

10.  Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica.

Authors:  Rolando Herrero; Wim Quint; Allan Hildesheim; Paula Gonzalez; Linda Struijk; Hormuzd A Katki; Carolina Porras; Mark Schiffman; Ana Cecilia Rodriguez; Diane Solomon; Silvia Jimenez; John T Schiller; Douglas R Lowy; Leen-Jan van Doorn; Sholom Wacholder; Aimée R Kreimer
Journal:  PLoS One       Date:  2013-07-17       Impact factor: 3.240

View more
  42 in total

1.  A phase 1 trial of Vorinostat in combination with concurrent chemoradiation therapy in the treatment of advanced staged head and neck squamous cell carcinoma.

Authors:  Theodoros N Teknos; J Grecula; A Agrawal; M O Old; E Ozer; R Carrau; S Kang; J Rocco; D Blakaj; V Diavolitsis; B Kumar; P Kumar; Q Pan; M Palettas; L Wei; R Baiocchi; P Savvides
Journal:  Invest New Drugs       Date:  2018-12-19       Impact factor: 3.850

2.  The Natural History of Oral Human Papillomavirus in Young Costa Rican Women.

Authors:  Daniel C Beachler; Krystle A Lang Kuhs; Linda Struijk; John Schussler; Rolando Herrero; Carolina Porras; Allan Hildesheim; Bernal Cortes; Joshua Sampson; Wim Quint; Paula Gonzalez; Aimée R Kreimer
Journal:  Sex Transm Dis       Date:  2017-07       Impact factor: 2.830

3.  Human papillomavirus DNA detection, p16INK4a, and oral cavity cancer in a U.S. population.

Authors:  Brenda Y Hernandez; Charles F Lynch; Owen T M Chan; Marc T Goodman; Elizabeth R Unger; Martin Steinau; Trevor D Thompson; Maura Gillison; Christopher Lyu; Mona Saraiya
Journal:  Oral Oncol       Date:  2019-03-05       Impact factor: 5.337

4.  Epidemiology of Any and Vaccine-Type Anogenital Human Papillomavirus Among 13-26-Year-Old Young Men After HPV Vaccine Introduction.

Authors:  Emmanuel Chandler; Lili Ding; Pamina Gorbach; Eduardo L Franco; Darron A Brown; Lea E Widdice; David I Bernstein; Jessica A Kahn
Journal:  J Adolesc Health       Date:  2018-07       Impact factor: 5.012

5.  Assessing dentists' human papillomavirus-related health literacy for oropharyngeal cancer prevention.

Authors:  Coralia Vázquez-Otero; Cheryl A Vamos; Erika L Thompson; Laura K Merrell; Stacey B Griner; Nolan S Kline; Frank A Catalanotto; Anna R Giuliano; Ellen M Daley
Journal:  J Am Dent Assoc       Date:  2017-10-12       Impact factor: 3.634

Review 6.  Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma.

Authors:  Maura L Gillison; Anil K Chaturvedi; William F Anderson; Carole Fakhry
Journal:  J Clin Oncol       Date:  2015-09-08       Impact factor: 44.544

7.  Feasibility and acceptance of oral human papillomavirus detection in the dental office: Results from The National Dental Practice-Based Research Network.

Authors:  D Brad Rindal; Gregg H Gilbert; Claudia Carcelén; Ellen Funkhouser; Emily Durand; David A Uppgaard; Jeff Fellows; Jana Ikeda; Alexander Ross Kerr; Branden Brar; Valeria V Gordan; Sudhir Agarwal; Peter Barnett; Robert K Pickard; Maura Gillison
Journal:  J Am Dent Assoc       Date:  2019-02       Impact factor: 3.634

8.  Oral health and human papillomavirus-associated head and neck squamous cell carcinoma.

Authors:  Angela L Mazul; James M Taylor; Kimon Divaris; Mark C Weissler; Paul Brennan; Devasena Anantharaman; Behnoush Abedi-Ardekani; Andrew F Olshan; Jose P Zevallos
Journal:  Cancer       Date:  2016-08-29       Impact factor: 6.860

9.  Association of serum cytokines with oral HPV clearance.

Authors:  Jennifer O Lam; Jay H Bream; Elizabeth A Sugar; Christian L Coles; Kathleen M Weber; Robert D Burk; Dorothy J Wiley; Ross D Cranston; Susheel Reddy; Joseph B Margolick; Howard D Strickler; Alicia Wentz; Lisa Jacobson; Yingshi Guo; Weihong Xiao; Maura L Gillison; Gypsyamber D'Souza
Journal:  Cytokine       Date:  2016-04-08       Impact factor: 3.861

10.  Measures of economic advantage associated with HPV-positive head and neck cancers among non-Hispanic black and white males identified through the National Cancer Database.

Authors:  Caryn E Peterson; Shaveta Khosla; Gina D Jefferson; Faith G Davis; Marian L Fitzgibbon; Sally Freels; Timothy P Johnson; Kent Hoskins; Charlotte E Joslin
Journal:  Cancer Epidemiol       Date:  2017-03-07       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.